发明名称 TUMOR NECROSIS FACTOR-BINDING LIGAND
摘要 PROBLEM TO BE SOLVED: To obtain an antibody which selectively inhibits or promotes the different activities of TNF-α. SOLUTION: A ligand, such as a monoclonal antibody, specific to the different topographic regions of the TNF-α. When the ligand is bound to TNF, tumor regression, the induction of endothelial procoagulant, the induction of tumor fibrin deposition, cytotoxicity, and the activity of receptor bonding are selectively influenced. As the preferable examples of the ligand, antibodies, F(ab) fragments, reconstituted antibody (CDR-planted human antibody), single domain antibodies (dAbs), single strand antibodies, serum-bound proteins, and receptors are cited. COPYRIGHT: (C)2003,JPO
申请公布号 JP2003231699(A) 申请公布日期 2003.08.19
申请号 JP20030024901 申请日期 2003.01.31
申请人 PEPTECH LTD 发明人 RATHJEN DEBORAH ANN;ASTON ROGER
分类号 A61K38/00;A61K45/00;A61K47/48;A61P35/00;A61P35/02;C07K14/435;C07K14/47;C07K14/52;C07K14/525;C07K16/00;C07K16/18;C07K16/24;C07K19/00;C12N5/10;C12N5/20;C12N15/02;C12N15/06;C12N15/09;C12P21/08;C12R1/91;(IPC1-7):C07K16/24 主分类号 A61K38/00
代理机构 代理人
主权项
地址